Edition:
United Kingdom

Aeterna Zentaris Announces FDA Approval Of Macrilen For Diagnosis Of Adult Growth Hormone Deficiency


Wednesday, 20 Dec 2017 

Dec 20 (Reuters) - Aeterna Zentaris Inc ::AETERNA ZENTARIS ANNOUNCES FDA APPROVAL OF MACRILEN™ (MACIMORELIN) FOR DIAGNOSIS OF ADULT GROWTH HORMONE DEFICIENCY.AETERNA ZENTARIS - INTENDS TO MAKE MACRILEN AVAILABLE COMMERCIALLY IN UNITED STATES DURING Q1 OF 2018. 

Company Quote

3.14
-0.05 -1.57%
24 May 2019